A study of 150 households has found that recurrent methicillin-resistant Staphylococcus aureus skin and other soft-tissue infections (MRSA SSTIs) may be associated with persistent MRSA colonization of household members and contamination of environmental surfaces, US researchers reported yesterday in JAMA Pediatrics.
The findings question the "more is better" mantra for preventing MRSA.
Nearly a fourth of MRSA bloodstream infections were tied to injection drug use.
A beta-lactam added to standard antibiotic therapy did not result in significant improvement.
The US Food and Drug Administration (FDA) has requested that manufacturers of bacitracin for injection voluntarily withdraw their products from the market.
The Ebola outbreak in the Democratic Republic of the Congo (DRC) grew by 2 cases today, bringing the total to 3,420, including 2,240 deaths. Six hundred cases are still under investigation, according to the online Ebola dashboard maintained by the World Health Organization (WHO).
The study shows how tolerance promotes the evolution of resistance with combination antibiotics.
The US Food and Drug Administration (FDA) today approved a new test to diagnose methicillin-resistant Staphylococcus aureus (MRSA), which will allow health workers to screen patients for MRSA colonization more quickly—in as little as 5 hours compared with 24 to 48 hours for traditional culture-based tests.
MRSA is driven both by introduction of novel strains and by transmission within the household, the study found.
Neonatal intensive care units (NICUs) participating in a quality improvement (QI) collaborative increased adherence to the US Centers for Disease Control and Prevention (CDC) core elements of antibiotic stewardship dramatically and cut antibiotic use by a third, according to a study today in Pediatrics.